PRA-027

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

FibroidUterine Leiomyomata (Fibroids)

Phase 1

Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential

CompletedNCT00427544

Wyeth is now a wholly owned subsidiary of PfizerFibroid

Start: 2007-02-28End: 2007-08-31Updated: 2007-12-05

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females

CompletedNCT00444704

Wyeth is now a wholly owned subsidiary of PfizerUterine Leiomyomata (Fibroids)

Start: 2007-03-31End: 2007-12-31Updated: 2009-07-10

Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women

CompletedNCT00543790

Wyeth is now a wholly owned subsidiary of PfizerUterine Leiomyomata (Fibroids)

Start: 2007-11-30End: 2008-12-31Updated: 2010-10-28